USPTO serial 78842114
PHYTOLAND
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BUONGIORNO, CHRISTOPHER L
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PHYTOLAND?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kenneth F. Florek
Kenneth F. Florek FLOREK & ENDRES PLLC1156 Avenue of the AmericasSuite 600New York, NY 10036-2702Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for use in the treatment of infection of respiratory tract, infection of urinary tract, urinary obstruction, chronic venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of the liver; pharmaceutical preparations, namely, plant extracts for pharmaceutical purposes, namely, for use in the treatment of angina, atherosclerosis, bronchial asthma, circulatory disorders, constipation, diarrhea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting and allergy; pharmaceutical preparations, namely, plant extracts for use as an antidepressant, diuretic, hypnotic, sedative, stimulant and tranquilizer; hemorrhcidal ointments, laxatives, nasal decongestant capsules. decongestant nasal sprays, non-narcotic analgesic, throat lozenges; medicinal preparations for the treatment of gynecological disorders; menstruation circulation regulating tablets, medicinal preparations for circulatory organs, hormone preparations, medicinal preparations for urinary, genital and anal organs, medicinal preparations for blood conditions, namely, blood thinning medicines, pills for treating dizziness, immune regulators; pharmaceutical preparations and medicines for the treatment of women's diseases, namely, migraine and depression; medicines for treatment of breast pain; medicines for treating climacteric complaints, premenstrual syndrome and dysmenorrhoea; pharmaceutical preparations and medicines for the treatment of gynecological disorders affecting menstruation, sterility, menstruous syndromes, mammae, mastopathie, mastodynia, climacteric complaints, premenstrual syndrome, dysmenorrhoea; sanitary preparations for medical purposes; medical plasters, bandages and gauze for dressings of wounds and cuts; disinfectants for sanitary purposes; dietetic food supplements containing plant extracts; food supplements derived from plants or plant extracts adapted for medical use; vegetable extracts for medical, veterinary and pharmaceutical purposes; tinctures and aromatic substances in liquid, solid or gaseous form for pharmaceutical preparations for use in the treatment of infection of respiratory tract, infection of urinary tract, urinary obstruction, chronic venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of the liver, angina, atherosclerosis, bronchial asthma, circulatory disorders, constipation, diarrhea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting and allergy, gynecological disorders, women's diseases, namely, migraine and depression, breast pain, climacteric complaints, premenstrual syndrome, dysmenorrhoea and dizziness, and for use as an antidepressant, diuretic, hypnotic, sedative, stimulant and tranquilizer, menstruation circulation regulation, hormone preparation; dietetic foods derived from plants, adapted for medical use, namely, meal replacement bars, meal replacement drinks, dietary supplemental drinks, dietary food supplements and vitamin and mineral supplements; herb teas for medicinal purposes and medicinal teas; food supplements; vitamins for use as ingredients in food; mineral preparations for use as ingredients in food; preparations of trace elements for use as an additive in the preparation of food | ACTIVE | — |
| 016 | photographs; stationery; adhesives for stationery or household purposes | ACTIVE | — |
| 029 | proteins, animal oils and fats and oils and fats derived from plants for use as dietetic food additives for non-medical purposes, vegetable-based food bars, fruit-based food bars | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 27, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 15, 2009 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 15, 2009 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 12, 2008 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 12, 2008 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 12, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 13, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 12, 2008 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Mar 6, 2008 | FAXX | FAX RECEIVED | — |
| Feb 19, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 30, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 15, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 14, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 14, 2008 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jan 11, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 11, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 23, 2007 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 21, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2007 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 3, 2007 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Oct 25, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 17, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 17, 2007 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Oct 16, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 16, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 22, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Sep 22, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 7, 2007 | PAPER RECEIVED | — | |
| Jul 13, 2007 | CNCF | CONTINUATION OF FINAL REFUSAL MAILED | — |
| Jul 12, 2007 | CNCF | ACTION CONTINUING A FINAL - COMPLETED | — |
| Jul 9, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jul 9, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 5, 2007 | PAPER RECEIVED | — | |
| Mar 22, 2007 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 21, 2007 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 2, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 2, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 2, 2007 | ALIE | ASSIGNED TO LIE | — |
| Feb 2, 2007 | PAPER RECEIVED | — | |
| Aug 2, 2006 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 2, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 1, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 24, 2006 | NWAP | NEW APPLICATION ENTERED | — |